At NINGBO INNO PHARMCHEM CO.,LTD., we understand that the efficacy of pharmaceuticals relies heavily on the quality and availability of their constituent intermediates. One such critical component is 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one, known by its CAS number 199327-61-2. This compound is not just another chemical; it is a vital stepping stone in the intricate synthesis of Gefitinib, a targeted therapy agent widely used in oncology. The precise molecular formula, C16H21N3O4, and molecular weight of 319.36 g/mol, are indicative of its complex structure, tailored for specific chemical reactions.

The journey of a drug from concept to patient involves numerous stages, and the role of intermediates like CAS 199327-61-2 is indispensable. The ability to source high-purity compounds is crucial for ensuring that the final product, Gefitinib, meets stringent regulatory requirements and therapeutic standards. NINGBO INNO PHARMCHEM CO.,LTD. plays a pivotal role in this ecosystem by providing a reliable supply of this essential pharmaceutical intermediate. Our commitment to quality assurance means that we meticulously control every aspect of production, from raw material sourcing to final product analysis, ensuring that each batch adheres to the required specifications for Gefitinib synthesis.

The broader implications for the API manufacturing supply chain are significant. A consistent supply of intermediates like 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one is fundamental for pharmaceutical companies to maintain production schedules and meet global demand for critical medications. By focusing on the reliable provision of such compounds, NINGBO INNO PHARMCHEM CO.,LTD. contributes to the stability and efficiency of this vital industry. The market for these specialized chemicals, often referred to as medicinal chemistry building blocks, is competitive, and our dedication to excellence sets us apart.

For researchers and developers, the accessibility to compounds like 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one is critical for ongoing research and the development of next-generation therapeutics. The pursuit of new and improved treatments necessitates a robust network of chemical suppliers who can deliver on both quality and quantity. NINGBO INNO PHARMCHEM CO.,LTD. is committed to being such a partner, facilitating the groundbreaking work that leads to better health outcomes for people worldwide. The demand to buy 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one reflects its fundamental importance in advancing pharmaceutical science.